Open-label Safety Study in Adults With ADHD

Clinical trial NCT02160262 · COMPLETED

Trial details

NCT number: NCT02160262
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Adult Attention Deficit Hyperactivity Disorder

Start date: 2014-06-01
Primary completion: 2016-05-01
Enrollment: 724

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.